These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25969566)

  • 21. Managing Behavioral and Psychological Symptoms of Dementia.
    Gerlach LB; Kales HC
    Psychiatr Clin North Am; 2018 Mar; 41(1):127-139. PubMed ID: 29412841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementia.
    Muramatsu RS; Litzinger MH; Fisher E; Takeshita J
    Am J Geriatr Pharmacother; 2010 Apr; 8(2):98-114. PubMed ID: 20439060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of PRN medications and use of nonpharmacologic interventions in acute geropsychiatric settings: implications for practice.
    Lindsey PL; Buckwalter KC
    J Am Psychiatr Nurses Assoc; 2012; 18(2):82-90. PubMed ID: 22442015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
    Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of pro re nata medications in acute inpatient care.
    Stein-Parbury J; Reid K; Smith N; Mouhanna D; Lamont F
    Aust N Z J Psychiatry; 2008 Apr; 42(4):283-92. PubMed ID: 18330770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Administration of
    Jimu M; Doyle L
    Issues Ment Health Nurs; 2019 Jun; 40(6):511-517. PubMed ID: 30917088
    [No Abstract]   [Full Text] [Related]  

  • 27. Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up.
    Martinho E; Fitzmaurice GM; Frankenburg FR; Zanarini MC
    J Clin Psychopharmacol; 2014 Aug; 34(4):499-503. PubMed ID: 24875066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia in a Geriatric Psychiatry Unit: A Retrospective Analysis.
    Quante A; Sulejmani A
    Prim Care Companion CNS Disord; 2017 Jul; 19(4):. PubMed ID: 28767205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription Benzodiazepine Use Among Older Adults: A Critical Review.
    Gerlach LB; Wiechers IR; Maust DT
    Harv Rev Psychiatry; 2018; 26(5):264-273. PubMed ID: 30188338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are there sensitive time periods for dementia caregivers? The occurrence of behavioral and psychological symptoms in the early stages of dementia.
    Ornstein KA; Gaugler JE; Devanand DP; Scarmeas N; Zhu CW; Stern Y
    Int Psychogeriatr; 2013 Sep; 25(9):1453-62. PubMed ID: 23725657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of behavioral and psychological symptoms of dementia and psychotropic drug treatments among old people in geriatric care in 2000 and 2007.
    Lövheim H; Gustafson Y; Karlsson S; Sandman PO
    Int Psychogeriatr; 2011 Dec; 23(10):1616-22. PubMed ID: 21902862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing.
    Walsh KA; O'Regan NA; Byrne S; Browne J; Meagher DJ; Timmons S
    Int Psychogeriatr; 2016 Nov; 28(11):1807-1820. PubMed ID: 27527842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings.
    Gustafsson M; Sandman PO; Karlsson S; Gustafson Y; Lövheim H
    Int Psychogeriatr; 2013 Sep; 25(9):1415-23. PubMed ID: 23782794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.
    Herrmann N; Lanctôt K; Myszak M
    J Clin Psychopharmacol; 2000 Feb; 20(1):90-3. PubMed ID: 10653214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.
    Wang LY; Shofer JB; Rohde K; Hart KL; Hoff DJ; McFall YH; Raskind MA; Peskind ER
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):744-51. PubMed ID: 19700947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sundown syndrome: is it reflected in the use of PRN medications for nursing home residents?
    Exum ME; Phelps BJ; Nabers KE; Osborne JG
    Gerontologist; 1993 Dec; 33(6):756-61. PubMed ID: 8314102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuing the Use of PRN Intramuscular Medication for Agitation in an Acute Psychiatric Hospital.
    Hayes A; Russ MJ
    Psychiatr Q; 2016 Mar; 87(1):25-9. PubMed ID: 25869884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.